Extrait

This trial will evaluate safety and efficacy of BI 10773 in hypertensive patients with type 2 diabetes. Since hyperglycaemia and hypertension are key risk factors for both micro- and macrovascular complications, assessment of both glucose and blood pressure lowering effects of BI 10773 in hypertensive patients with type 2 diabetes could provide clinically highly relevant, new information for the use of BI 10773

Critère d'inclusion

• Diabetes Mellitus, Type 2 ,Hypertension

Pays

• Canada
• Czech Republic
• Denmark
• Estonia
• Finland
• France
• Germany
• Lebanon
• Netherlands
• Norway
• Sweden
• United States

Liens

• nct
• ictrp